Literature DB >> 35304381

Arterial and venous thrombotic stroke after ChAdOx1 nCoV-19 vaccine.

Adrian Wills1, Gillian Swallow1, Matthew A Kirkman1, Krishna Rajan2, Ganesh Subramanian2.   

Abstract

Vaccine-induced thrombosis with thrombocytopenia (VITT) is a recently-described condition associated with arterial and venous thrombosis following vaccination with the ChAdOx1 nCoV-19 (AstraZeneca) vaccine. This report describes two cases of stroke caused by arterial and venous thromboses presenting within 28 days of receiving the AstraZeneca vaccine. The patients were otherwise young and healthy with minimal risk factors for thrombosis yet developed a rapid, ultimately fatal neurological deterioration.The patients were significantly thrombocytopenic with disproportionately raised D-dimers, both of which are widely reported in this condition. Both cases had measurable immunoglobulin G platelet factor-4 antibodies detected via enzyme-linked immunosorbent assay, similar to those described in heparin-induced thrombocytopenia.These cases illustrate that physicians should be especially mindful of VITT in the context of evolving evidence on treatment and in view of the potentially rapid and catastrophic neurological deterioration, leading to fatality despite best supportive care. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  COVID-19; stroke; thrombocytopenia; thrombosis; vaccination

Mesh:

Substances:

Year:  2022        PMID: 35304381      PMCID: PMC8966826          DOI: 10.7861/clinmed.2021-0321

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  4 in total

1.  Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.

Authors:  Johannes Oldenburg; Robert Klamroth; Florian Langer; Manuela Albisetti; Charis von Auer; Cihan Ay; Wolfgang Korte; Rüdiger E Scharf; Bernd Pötzsch; Andreas Greinacher
Journal:  Hamostaseologie       Date:  2021-04-01       Impact factor: 1.778

2.  Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.

Authors:  Marie Scully; Deepak Singh; Robert Lown; Anthony Poles; Tom Solomon; Marcel Levi; David Goldblatt; Pavel Kotoucek; William Thomas; William Lester
Journal:  N Engl J Med       Date:  2021-04-16       Impact factor: 91.245

3.  Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology.

Authors:  Ishac Nazy; Ulrich J Sachs; Donald M Arnold; Steven E McKenzie; Phil Choi; Karina Althaus; Maria Therese Ahlen; Ruchika Sharma; Rachael F Grace; Tamam Bakchoul
Journal:  J Thromb Haemost       Date:  2021-04-22       Impact factor: 5.824

4.  Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

Authors:  Andreas Greinacher; Thomas Thiele; Theodore E Warkentin; Karin Weisser; Paul A Kyrle; Sabine Eichinger
Journal:  N Engl J Med       Date:  2021-04-09       Impact factor: 91.245

  4 in total
  2 in total

1.  The association of pleural effusion and pulmonary embolism.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Clin Med (Lond)       Date:  2022-05       Impact factor: 5.410

2.  Health means more than just healthcare.

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2022-03       Impact factor: 5.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.